2016 Press Releases

Intarcia logo

Save

Intarcia Secures Second Close of the Series EE Equity Financing for an Additional $206M; As Part of the Financing and a New Strategic Initiative, Intarcia Now Aims Its Medici Technology Towards Preventing HIV
December 29, 2016

Dimension logo

Save

Dimension Therapeutics Announces FDA Acceptance of Investigational New Drug Application for DTX301 to Treat OTC Deficiency
December 13, 2016

Arvinas logo

Arvinas Collaborators Present Data on BET PROTAC Degraders at 2016 ASH Annual Meeting
December 6, 2016

Deciphera logo

Deciphera Pharmaceuticals Reports Encouraging Clinical Results with DCC-2618 in Genetically-defined Cancers with Drug Resistant Mutations
December 1, 2016

AiCure logo

Save

Save

AiCure’s Artificial Intelligence Platform Wins 2016 Scrip Award
December 1, 2016

Arvinas logo

Save

Arvinas Presents Data on its BET PROTAC Degraders at 2016 EORTC-NCI-AACR Symposium
November 29, 2016

Intarcia logo

Intarcia Submits New Drug Application (NDA) to FDA for U.S. Marketing Approval of ITCA 650 in Type 2 Diabetes
November 21, 2016

Truveris logo

Truveris Ranked Number 131 Fastest Growing Company in North America on Deloitte’s 2016 Technology Fast 500™
November 16, 2016

Kyruus logo

UAB Medicine Selects Kyruus for Patient-Provider Matching and Provider Data Management
November 14, 2016

Versartis Logo

Versartis Presents Safety, Efficacy and IGF-I Data for Somavaratan in Pediatric Growth Hormone Deficiency at the 2016 Congress of the GRS & IGF Society
November 7, 2016

Kyruus logo

The Ohio State University Wexner Medical Center Implements Kyruus ProviderMatch to Optimize Patient Access
October 26, 2016

TigerText Logo

TigerText Introduces TigerFlow, The Next Evolution In Clinical Communications
October 20, 2016

Crispr logo

CRISPR Therapeutics Announces Pricing of Initial Public Offering
October 18, 2016

True North Therapeutics logo

True North Therapeutics Announces $45 Million Series D Financing
October 18, 2016

True North Therapeutics logo

True North Therapeutics Receives FDA Orphan Drug Designation for TNT009 for the Treatment of Autoimmune Hemolytic Anemia, Including Cold Agglutinin Disease (CAD)
October 13, 2016

Oxford Immunotec Logo

Oxford Immunotec Acquires Immunetics, Inc.
October 12, 2016

Kyruus logo

Kyruus Appoints John Downey as Senior Vice President of Sales
October 7, 2016

Oxford Immunotec Logo

Oxford Immunotec Announces Closing of $40 Million in Debt Financing
October 4, 2016

Oxford Immunotec Logo

Oxford Immunotec Announces Favorable Decision from U.S. District Court of Massachusetts in Patent Infringement Litigation
October 3, 2016

Versartis Logo

Save

Versartis Initiates Phase 3 Trial of Somavaratan in Japan for Children with Growth Hormone Deficiency Following Completion of Phase 2
September 26, 2016

Truveris logo

Save

Truveris Strengthens Leadership Team with Appointment of Faisal Mushtaq as Chief Executive Officer
September 22, 2016

Intarcia logo
Save

Intarcia Completes First Close of a Major Equity Financing; Poised for ITCA 650 NDA Filing for Type 2 Diabetes, Commercial Readiness and Pipeline Progression
September 15, 2016

Kitcheck logo

Save

Kit Check Adds Former QSI/NextGen Healthcare Sales Leader Gary Voydanoff as New Chief Commercial Officer
September 15, 2016

Versartis Logo

Save

Save

Versartis Presents Data From Up to 30 Months of Somavaratan Treatment for Pediatric Growth Hormone Deficiency at the 2016 ESPE Annual Meeting
September 12, 2016

Versartis Logo

Save

Versartis Announces Completion of Enrollment in Phase 3 VELOCITY Trial of Somavaratan in Pediatric GHD
August 22, 2016

Versartis Logo

Teijin Limited and Versartis Enter Strategic Alliance for Commercialization of Somavaratan Long-Acting Growth Hormone in Japan
August 9, 2016

Reshape medical logo

Save

ReShape Medical® Announces the Appointment of Michael J. Mangano as President and Chief Executive Officer
August 8, 2016

Kitcheck logo

Kit Check Names Cameron Ferroni as Chief Product Officer
August 7, 2016

Edge Therapeutics

Edge Therapeutics Announces Closing of $20 Million Debt Facility with Hercules Capital, Inc.
August 2, 2016

Edge Therapeutics

Edge Therapeutics Announces First Patient Treated in Phase 3 NEWTON 2 Study of EG-1962 in Adult Patients with Aneurysmal Subarachnoid Hemorrhage
July 29, 2016

TigerText Logo

TigerText Earns Prestigious HITRUST CSF Certification
July 27, 2016

CardioKinetix

CardioKinetix Announces the 500th Parachute Heart Failure Device Implantation July 21, 2016
July 21, 2016

Aptinyx logo

Aptinyx Initiates Dosing in Phase 1 Clinical Study of Lead NMDA-Receptor Modulator, NYX-2925
July 13, 2016

Dimension logo

Aptuit LLC and Dimension Therapeutics Enter Strategic Partnership to Advance Select Dimension Programs Toward IND Filing
July 7, 2016

Edge Therapeutics

Edge Therapeutics Announces Appointment of Harry J. Sacks, M.D., FAAP, as Vice President, Clinical Development
July 6, 2016

ACD website

Bio-Techne Announces Agreement to Acquire Advanced Cell Diagnostics
July 7, 2016

CRISPR logo

CRISPR Therapeutics Raises Additional $38M as Part of Series B Financing
June 24, 2016

Unum logo

Unum Therapeutics Announces Active Investigational New Drug (IND)
June 20, 2016

Kitcheck logo

Kit Check Closes $15 Million Series C Round
June 20, 2016

Afferent Pharmaceuticals Logo

Merck to Acquire Afferent Pharmaceuticals
June 9, 2016

Arvinas logo

Arvinas Publishes First Peer-Reviewed, In Vivo Data from its Proprietary PROTAC Technology
June 7, 2016

TigerText Logo

TigerText and Honeywell Collaborate to Increase Healthcare Organizational Efficiency and Enhance Patient Experience
June 2, 2016

Afferent Pharmaceuticals Logo

Afferent Pharmaceuticals Presents Updated Positive Results with AF-219 from Phase 2B Chronic Cough Study at the 2016 American Thoracic Society (ATS) International Conference
May 16, 2016

TigerText Logo

TigerConnect Healthcare Bot Set to Automate the Future of Healthcare Information
May 12, 2016

Aptinyx logo

Aptinyx Raises $65 Million in Series A Financing to Advance Therapies for Neurological Disorders
May 10, 2016

Intarcia logo

Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes
May 6, 2016

iRhythm Logo

iRhythm Technologies Expands ZIO® Service to Include True Atrial Fibrillation Duration Reporting
April 28, 2016

Kyruus logo

MedStar Health Selects Kyruus to Build Patient Access Experience
April 28, 2016

TigerText Logo

New Hampshire Health Information Organization Upgrades Communication System, Selects TigerText Secure Messaging Platform
April 19, 2016

Treato Logo

Treato Finds DTC Pharma TV Advertisements Have Little Influence
April 18, 2016

Karos Pharmaceuticals logo

Karos Pharmaceuticals Advances Development of KAR5585 to Treat Pulmonary Arterial Hypertension into the Clinic
April 13, 2016

Versartis Logo

Versartis Presents Confirmatory 18-Month Adherence Data from Ongoing Somavaratan Extension Study at Late-Breaker Session at ENDO Annual Meeting
April 1, 2016

Versartis Logo

Versartis Appoints Colin Hislop, M.D., as Chief Medical Officer
March 30, 2016

iRhythm Logo

New Study Suggests High Burden of Atrial Fibrillation is Associated with Lower Cognitive Function
March 22, 2016

Kitcheck logo

Kit Check Tracks 10 Million Hospital Medications to Become Largest Scale IoT and Cloud Software Solution in Healthcare
March 17, 2016

Dimension logo

Dimension Therapeutics Receives Positive Opinion for European Orphan Drug Designation for DTX301 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency
March 17, 2016

Versartis Logo

Versartis Announces Two Abstracts from Ongoing Pediatric Extension Study of Somavaratan Selected for Late-Breaker Presentations at the Endocrine Society’s 98th Annual Meeting
March 14, 2016

Arvinas logo

Arvinas Appoints Angela Shen as Chief Medical Officer
March 2, 2016

AwarePoint Logo

Awarepoint Showcases the Industry’s First Wi-Fi Managed BLE Beacon
March 1, 2016

Kyruus logo

Summa Health Selects ProviderMatch to Power Access for Clinically Integrated Network
March 1, 2016

TigerText Logo

TigerText Announces Deeper Integration with BOX to Provide Healthcare Teams with Secure Messaging Capabilities for DICOM Image Collaboration
February 29, 2016

Kyruus logo

Beaumont Health and Kyruus Partner to Provide an “Omnichannel” Experience for Patients
February 23, 2016

Edge Therapeutics

Edge Therapeutics Announces New Data Highlighting the Potential Pharmacoeconomic Impact of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
February 19, 2016

AwarePoint Logo

Kaiser’s Zion Medical Center Wins IHA 2016 Award
February 16, 2016

Versartis Logo

Versartis Reports Confirmatory Top-Line Two-Year Data from Ongoing Extension Study of Somavaratan in GHD Children
February 2, 2016

IC_aicure_press

AiCure’s Artificial Intelligence Platform Draws $12.25 Million Series A
January 11, 2016

Biopharma_principia_press

Principia Biopharma advances BTK inhibitor program in autoimmune disease and FGFR inhibitor program in oncology
January 7, 2016

Dimension logo

Dimension Therapeutics Announces Initiation of Phase 1/2 Study for DTX101 for the Treatment of Hemophilia B
January 7, 2016

Dimension logo

Dimension Therapeutics Announces Orphan Drug Designation of DTX301 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency
January 6, 2016

Biopharma_deciphera_press

Deciphera Pharmaceuticals Increases Size of Series B Financing to over $90 Million with Addition of SV Life Sciences
January 5, 2016